Bagyzhan Syzdykova

Dr. Bagyzhan Syzdykova

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SKSamat Kozhakhmetov
Samat Kozhakhmetov
AKAlibek Kossumov
Alibek Kossumov
TZTolkyn Zhakupova
Tolkyn Zhakupova
TPTatyana Polyakova
Tatyana Polyakova
NINazgul Imambayeva
Nazgul Imambayeva
AKAlmagul Kushugulova
Almagul Kushugulova
Growing evidence supports a bidirectional relationship between the gut microbiome and mental health. This study investigated the association between gut microbiota, depression, and suicidal behavior by analyzing fecal samples from 35 individuals with varying depression levels and 36 completed suicide cases. Standardized psychometric assessments were used for depression evaluation. Analysis revealed significant taxonomic differences between groups, with increased abundance of Firmicutes, Clostridia, Lachnospiraceae, Blautia, and Dorea in suicide cases, which also positively correlated with depression severity. Metabolic pathway analysis demonstrated a notable dichotomy: suicide cases showed elevated pathways related to infection processes, inflammation, and antibiotic resistance, while the control group exhibited higher energy metabolism and vitamin synthesis pathways. The findings establish specific microbiome profiles associated with both depression symptoms and suicidal behavior, suggesting that gut dysbiosis may influence mental health through altered energy metabolism and inflammatory processes, potentially offering new perspectives for diagnostic and therapeutic approaches.

23 October 2026 in Astana Medical Journal
Verified
Journal Article
Closed access
ZBZhanibek Baiturlin
Zhanibek Baiturlin
DBDaultay Batyrkhanov
Daultay Batyrkhanov
АDАlisher Dauytov
Аlisher Dauytov
BSBagyzhan Syzdykova
Bagyzhan Syzdykova
AKAlmira M Kustubayeva
Almira M Kustubayeva
DKDaniyar Kalmagambetov
Daniyar Kalmagambetov
Introduction. MRI is the primary method for diagnosing multiple sclerosis; however, many MRI findings lack sufficient specificity and are also observed in vascular, inflammatory, and degenerative diseases of the central nervous system. One of the most extensively studied markers of the perivenular origin of demyelinating lesions is the “central vein sign.” It is considered an additional marker for improving diagnostic accuracy and reducing the risk of misdiagnosis. The clinical significance of the central vein sign is emphasized in the 2024 McDonald criteria. Objective. To analyze the diagnostic specificity of the “central vein sign” on 3T MRI in patients with multiple sclerosis and determine its role within the framework of the updated 2024 McDonald criteria. Materials and Methods. A structured review of publications from the PubMed and Scopus databases published between 2015 and 2025 and addressing the diagnostic performance of the “central vein sign” on 3T MRI was conducted. The analysis included specificity measures, threshold values, detection techniques, and its potential application in the differential diagnosis of diseases that mimic multiple sclerosis. Results. The presence of the “central vein sign” in white matter lesions is associated with high specificity for the diagnosis of multiple sclerosis. Threshold-based approaches assessing the proportion of pathological lesions proved most effective, including the criterion of at least 40% of such lesions and the “Select-6” rule. 3T MRI using susceptibility- sensitive sequences (SWI, SWAN) enables visualization of the central vein sign in routine clinical practice. According to most studies, incorporating this criterion into the diagnostic algorithm increases specificity compared with the isolated application of the criteria for dissemination in space and time, without a substantial reduction in sensitivity, thereby contributing to more accurate differential diagnosis. Conclusion: The “central vein sign” is a promising supplementary MRI criterion for improving the specificity of multiple sclerosis diagnosis on 3T MRI. In the 2024 McDonald criteria, it is considered an adjunctive tool rather than an independent diagnostic criterion. Further implementation of this criterion requires standardization of imaging protocols, improvement of assessment methods, and additional validation of its diagnostic significance across different clinical groups. Keywords: multiple sclerosis (MS), central vein sign (CVS), 3T MRI, 2024 McDonald criteria, SWAN/SWI.

17 August 2026 in Georgian Medical Journal
Verified
Journal Article
Open access
PDF file
SKSairan Kozhakanova
Sairan Kozhakanova
DADinara Alzhanova
Dinara Alzhanova
BSBagyzhan Syzdykova
Bagyzhan Syzdykova
BKBauyrzhan Kaliyev
Bauyrzhan Kaliyev
AYAktoty Yestibayeva
Aktoty Yestibayeva
ADAlina Dospayeva
Alina Dospayeva
Modern research into Baló concentric sclerosis has revealed a characteristic neuroradiological picture, while clinical manifestations range widely, including benign and malignant forms of demyelinating disease. Immunological diagnostics remain poorly characterised. We report a 17-year-old Caucasian male from Kazakhstan who initially presented to the emergency department with acute focal neurological deficits, including right-sided hemiparesis and gait unsteadiness, mimicking acute ischaemic stroke. Brain magnetic resonance imaging revealed multifocal lesions in the thalamus, temporal, and parietal lobes with pronounced diffusion restriction, confirming Baló concentric sclerosis. Following high-dose intravenous methylprednisolone, rapid neurological improvement was observed. A subsequent relapse led to the diagnosis of relapsing-remitting multiple sclerosis, and disease-modifying therapy with ocrelizumab was initiated with a satisfactory response. This case demonstrates that Pattern I demyelination can underlie atypical variants evolving into classical multiple sclerosis, highlighting the need to combine neuroimaging with immunopathological profiling to predict disease trajectories. Keywords: Baló concentric sclerosis; multiple sclerosis; concentric ring lesions; demyelinating disease; ocrelizumab; corticosteroid treatment; case report